Zanamivir
Y. Vivian Tsai, Pharm.D., Paul G. Auwaerter, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Uncomplicated acute illness due to influenza A and B infection (patients > 7 yrs of age with < 48hr symptoms).
- Clinical benefit is best established when treatment is initiated within 48 hours of symptom onset in uncomplicated influenza.
- It is FDA-approved for treatment in patients aged 7 years and older, but use is limited by inhaled administration and is not recommended in patients with asthma, COPD, or other underlying airway disease.
- Influenza prophylaxis in those 5 years of age or older.
- Not proven effective for prophylaxis in nursing home residents.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.